Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Thomas Willows"'
Autor:
Caroline Ran, Karin Wirdefeldt, Lovisa Brodin, Mehrafarin Ramezani, Marie Westerlund, Fengqing Xiang, Anna Anvret, Thomas Willows, Olof Sydow, Anders Johansson, Dagmar Galter, Per Svenningsson, Andrea Carmine Belin
Publikováno v:
Parkinson's Disease, Vol 2017 (2017)
Nuclear factor erythroid 2-like 2 (NRF2) encodes a transcription factor regulating mechanisms of cellular protection and is activated by oxidative stress. NRF2 has therefore been hypothesized to confer protection against Parkinson’s disease and so
Externí odkaz:
https://doaj.org/article/e7dbcf9dd3ef4e7a865416f7baddc886
Autor:
Arja Höglund, Peter Hagell, Thomas Willows, Johan Rådberg, Anders Johansson, Berit Löwed, Anne-Christine Sjöström, Nil Dizdar, Margareth Lundgren, Eva-Lena Johansson, Filip Bergquist, Carina Karlberg, Carina Hellqvist
Publikováno v:
Journal of Neurology
Continuous subcutaneous (s.c.) apomorphine infusion is an effective therapy for Parkinson’s disease (PD), but a limitation is the formation of troublesome s.c. nodules. Various chemically non-identical apomorphine formulations are available. Anecdo
Autor:
Jörgen Larsson, Peter Grenholm, Håkan Widner, Thomas Willows, Kristina Groth, Johan Permert, Susanna Kjellander, Ursula Schmiauke, Nil Dizdar, Dag Nyholm, Anna Urbom
Publikováno v:
Journal of Parkinson's Disease
Background: Levodopa-carbidopa intestinal gel (LCIG; Duodopa r) is used for continuous infusion in advanced Parkinsons disease. To achieve optimal effect, the LCIG dose is individually titrated, traditionally conducted during hospitalization in Swede
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686313abb7ec104a503e318933c9f539
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-143648
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-143648
Autor:
Anna Anvret, Olof Sydow, Andrea Carmine Belin, L.-A. Brodin, Marie Westerlund, Karin Wirdefeldt, Anders Johansson, Per Svenningsson, Fengqing Xiang, Thomas Willows, Caroline Ran, Mehrafarin Ramezani, Dagmar Galter
Publikováno v:
Parkinson's Disease, Vol 2017 (2017)
Parkinson's Disease
Parkinson's Disease
Nuclear factor erythroid 2-like 2 (NRF2) encodes a transcription factor regulating mechanisms of cellular protection and is activated by oxidative stress. NRF2 has therefore been hypothesized to confer protection against Parkinson’s disease and so
Autor:
Anna Håkansson, Olof Sydow, Andrea Carmine Belin, Peter Söderkvist, Marie Westerlund, Thomas Willows, Anna Anvret, Hans Nissbrandt, Silvia Paddock, Caroline Ran, Ahmad Ahmadi, Dagmar Galter, Maria Anvret, Nil Dizdar
Publikováno v:
Neuroscience Letters. 522:30-35
Pesticide exposure has been suggested to increase the risk to develop Parkinson's disease (PD). The arylesterase paraoxonase 1 (PON1) is mainly expressed in the liver and hydrolyzes organophosphates such as pesticides. The polymorphism Leu54Met (rs85
Autor:
Andrea Carmine Belin, Thomas Willows, Olof Sydow, Caroline Ran, Marie Westerlund, Lars Olson, Dagmar Galter, Anna Anvret
Publikováno v:
The Open Neurology Journal
MIRO1 and MIRO2 (mitochondrial Ras homolog gene family, member T1 and T2) also referred to as RHOT1 and RHOT2, belong to the mitochondrial Rho GTPase family and are involved in axonal transport of mitochondria in neurons. Because mitochondrial dysfun
Autor:
Thomas Willows, Olof Sydow, Marie Westerlund, Caroline Ran, Anna Håkansson, Andrea Carmine Belin, Jeff G. Blackinton, Anna Anvret, Hans Nissbrandt
Publikováno v:
The Open Neurology Journal
Mutations in the PARK7 gene, DJ-1, have been reported to cause early-onset and familial Parkinson’s disease (PD). The function of DJ-1 and how it contributes to the development of the disease is not clear today, but several studies report that DJ-1
Autor:
Charlotta Lind, Olof Sydow, Thomas Willows, Marie Westerlund, Dagmar Galter, Andrea Carmine Belin, Anna Anvret
Publikováno v:
Neuroscience Letters. 485:117-120
DNA polymerase gamma (POLG1) is coding for the catalytic subunit of the heterotrimeric mitochondrial DNA polymerase and involved in replication and repair of mitochondrial DNA. In addition to its 5' to 3' polymerase activity, POLG1 has a 3' to 5' exo
Autor:
Mevludin Memedi, Sven Pålhagen, Thomas Willows, Anders Johansson, Jan Linder, Jerker Westin, Dag Nyholm, Håkan Widner
The aim of this study was to investigate if a telemetry test battery can be used to measure effects of Parkinson’s disease (PD) treatment intervention and disease progression in patients with fluctuations. Sixty-five patients diagnosed with advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef41f3ad2a3641bdd69550f40ade30a6
http://urn.kb.se/resolve?urn=urn:nbn:se:du-19021
http://urn.kb.se/resolve?urn=urn:nbn:se:du-19021
Publikováno v:
International Journal of Integrated Care; Vol 16, ETC Conference Supplement 2016; S42
Purpose : Telemedicine can be used to find more cost and time efficient solutions, for both caregivers and patients. In an attempt to turn inpatient care to outpatient care, we have explored and evaluated a telemedicine solution where the patient can